An analysis of national U.S. health and diet data found a strong link between ultra-processed food consumption and cardiovascular disease. Adults whose diets were highest in ultra-processed foods—like sodas, packaged snacks, and processed meats—had a 47% higher risk of heart attack or stroke than those who ate the least, even after adjusting for other factors. The findings underscore ultra-processed foods as a major, preventable driver of heart disease and a pressing public health concern.

Korea University College of Medicine recently hosted a special lecture by Professor Adelheid Wöhrer from the Institute of Neuropathology and Neuro-Molecular Pathology at the Medical University of Innsbruck, Austria.

A peer reviewed, randomized controlled study with 199 women living in poverty in the city slums of Uganda was published today in Health Care for Women International. This study was conducted following two extended country-wide lockdowns in Uganda during the Covid 19 pandemic. Researchers found that the Transcendental Meditation® (TM®) technique reduced perceived stress, anger, and fatigue; increased self-efficacy; and improved sleep quality. TM helped these women to improve their mental and physical health and positively impacted their ability to cope in this crisis.

For decades, gynecological tests have relied on a simplified view of the vaginal microbiome, categorizing bacteria as either “good” or “bad.” New research from University of Maryland School of Medicine scientists challenges that assumption, revealing that bacteria of the same species can behave in fundamentally different ways, with important implications for women’s health.

NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory cytokines IL-1β and IL-18, and ISM5059 targets systemic inflammatory conditions by targeting NLRP3 and blocking the inflammatory cascade at its source.

Unlike ISM8969, Insilico’s brain-penetrant NLRP3 pipeline already with FDA IND clearance, ISM5059 features a completely different chemical core designed for peripheral-restricted potency.

Empowered by AI, ISM5059 demonstrated robust efficacy, excellent safety profiles in preclinical studies, and low predicted human efficacious dose, with high potential in multiple indications including autoimmune and chronic cardiometabolic diseases with no obvious CNS (central nervous system) related toxicity observed in preclinical studies.